Bootleg Market for Reta Reaches At Least $100 Million in Estimated Sales
Mirrored from The Information — AI for archival readability. Support the source by reading on the original site.
Demand for knockoff versions of retatrutide, a peptide-based drug being developed by Eli Lilly, has skyrocketed lately, propelling a gray market that likely exceeds $100 million in annual sales, according to an estimate prepared by The Information that examined many of the market’s biggest ...
More from The Information — AI
-
Anthropic’s Contradiction; The Risks of Buying SpaceX Stock Now
Jun 14
-
OpenAI, Anthropic Employees Have Already Cashed Out About $14 Billion
Jun 14
-
Exclusive: U.S. Government Unlikely to Extend Anthropic Export Control to Other AI Companies
Jun 13
-
Amazon’s Jassy Raised Concerns About Anthropic Model Before Trump Crackdown
Jun 13
Discussion (0)
Sign in to join the discussion. Free account, 30 seconds — email code or GitHub.
Sign in →No comments yet. Sign in and be the first to say something.